GRAY SUSANNAH has filed 9 insider transactions across 4 companies since May 2024.
Most recent transaction: a grant/award of 11250 shares of ANAPTYSBIO, INC ($ANAB) on April 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 27, 2026 | ANAPTYSBIO, INC | $ANAB | GRAY SUSANNAH | Not found | A | Restricted Stock Unit | 11250 | $0.00 | 11,250.0000 | 27,688,470 | 9999.99% | 0.04% |
| June 17, 2025 | 4D Molecular Therapeutics, Inc. | $FDMT | GRAY SUSANNAH | Not found | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 46,302,407 | 9999.99% | 0.05% |
| June 16, 2025 | MARAVAI LIFESCIENCES HOLDINGS, INC. | $MRVI | GRAY SUSANNAH | Director | A | Class A Common Stock | 89139 | $2.16 | 169,907.0000 | 137,906,000 | 110.36% | 0.06% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | GRAY SUSANNAH | Not found | A | Share Option (Right to Buy) | 24258 | $0.00 | 24,258.0000 | 49,706,000 | 9999.99% | 0.05% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | GRAY SUSANNAH | Not found | A | Ordinary Shares | 10649 | $0.00 | 42,137.0000 | 49,706,000 | 33.82% | 0.02% |
| May 23, 2024 | MARAVAI LIFESCIENCES HOLDINGS, INC. | $MRVI | GRAY SUSANNAH | Director | A | Class A Common Stock | 20645 | $10.78 | 80,768.0000 | 131,919,000 | 34.34% | 0.02% |
| May 21, 2024 | 4D Molecular Therapeutics, Inc. | $FDMT | GRAY SUSANNAH | Not found | A | Stock Option (Right To Buy) | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | GRAY SUSANNAH | Not found | A | Share Option (Right to Buy) | 23576 | $0.00 | 23,576.0000 | 48,283,000 | 9999.99% | 0.05% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | GRAY SUSANNAH | Not found | A | Ordinary Shares | 10537 | $0.00 | 31,488.0000 | 48,283,000 | 50.29% | 0.02% |